Investing.com -- Macquarie upgraded Atlassian Corp Plc (NASDAQ:TEAM) to "Outperform" from "Neutral" pointing to growing cross-departmental adoption, favourable near-term revenue catalysts, and an improved valuation profile. The firm set a new 12-month price target of $270, implying a 29% total shareholder return from current levels. Macquarie sees upside risk to FY25 revenue guidance, in part due to 15–25% Data Center price increases on post-February renewals. Longer-term, customer feedback suggests Atlassian is gaining traction with its "wall-to-wall" expansion strategy. No changes were made to earnings estimates. Following Atlassian’s “TEAM ‘25” customer and investor forum in Anaheim, Macquarie highlighted increased customer interest in broader use cases beyond software development. The launch of the Teamwork Collection, a new cloud bundle combining Jira, Confluence, Loom, and AI-powered Rovo agents, was cited as a key step in extending the company’s reach into non-technical functions such as HR, asset management, and customer service. The bundle supports TEAM’s strategic push to unify its apps through agentic AI, making workflows more dynamic and user-friendly, Macquarie wrote. The firm believes the integration can enhance productivity and user experience while driving enterprise-wide adoption. While the price target was lowered from $317 to $270 due to lower peer multiples, Macquarie said TEAM’s valuation now screens attractively across EV/revenue and EV/free cash flow metrics. The stock now trades in-line with peers versus its historical 15% premium, as per the note. Macquarie also highlighted the company’s AI-led innovation, particularly Rovo’s capabilities and growing third-party integration. Atlassian’s architecture evolution, toward modular apps with simplified navigation and bundled offerings, was seen as key to supporting long-term scalability. TEAM is set to report March-quarter earnings on May 1, with Macquarie pointing to CY25 revenue visibility as a potential catalyst. Related articles Macron Says Ukraine Deserves to Be in NATO, Just Not Right Now Big Tech Powers Stock Gains in Run-Up to Jobs Data: Markets Wrap BARK earnings missed, revenue topped estimates View Comments
Macquarie upgrades Atlassian on product momentum and attractive valuation
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...